Non-thrombotic hematologic manifestations in APS

Antiphospholipid Antibody Syndrome: From Bench to Bedside

Volumn , Issue , 2015, Pages 113-126

  Barcellini, Wilma ^a   Artusi, Carolina ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoimmune hemolytic anemia; Immune thrombocytopenia; Neutropenia

Indexed keywords

EID: 84944626575     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-11044-8_10     Document Type: Chapter

References (66)

1. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M, Euro- Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019-1027
2. Hughes GR (1993) The antiphospholipid syndrome: ten years on. Lancet 342(8867):341-344
3. Cuadrado MJ, Mujic F, Muñoz E, Khamashta MA, Hughes GR (1997) Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis 56(3):194-196
4. Galli M, Finazzi G, Barbui T (1996) Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol 93(1):1-5
5. Italian Registry of Antiphospholipid Antibodies [IR-APA]. Thrombosis and thrombocytopenia in antiphospholipid syndrome [idiopathic and secondary to SLE]: first report from the Italian Registry (1993). Haematologica 78(5):313-8
6. Uthman I, Godeau B, Taher A, Khamashta M (2008) The hematologic manifestations of the antiphospholipid syndrome. Blood Rev 22(4):187-194
7. Lechner K, Pabinger-Fasching I (1985) Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 15(4):254-262
8. Cuker A, Cines DB (2010) Immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2010:377-384
9. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of Hematology (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190-4207
10. Ghanima W, Godeau B, Cines DB, Bussel JB (2012) How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 120(5):960-969
11. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97(9):2549-2554
12. Enger C, Bennett D, Forssen U, Fogarty PF, McAfee AT (2010) Comorbidities in patients with persistent or chronic immune thrombocytopenia. Int J Hematol 92(2):289-295
13. Nørgaard M, Jensen AØ, Engebjerg MC, Farkas DK, Thomsen RW, Cha S, Zhao S, Sørensen HT (2011) Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Blood 117(13):3514-3520
14. Kim KJ, Baek IW, Yoon CH, Kim WU, Cho CS (2013) Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies. Br J Haematol 161(5):706-714
15. Bevers EM, Smeets EF, Comfurius P, Zwaal RF (1994) Physiology of membrane lipid asymmetry. Lupus 3(4):235-240
16. Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, Palomo I, Harris EN, Meroni PL (2008) Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34(3):236-250
17. Galli M, Daldossi M, Barbui T (1994) Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thromb Haemost 71(5):571-575
18. Fabris F, Steffan A, Cordiano I, Borzini P, Luzzatto G, Randi ML, Girolami A (1994) Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia. Eur J Haematol 53(4):232-236
19. Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B, Nurden AT (1997) Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 98(2):336-341
20. Godeau B, Piette JC, Fromont P, Intrator L, Schaeffer A, Bierling P (1997) Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 98(4):873-879
21. Harris EN, Gharavi AE, Hegde U, Derue G, Morgan SH, Englert H, Chan JK, Asherson RA, Hughes GR (1985) Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59(2):231-234
22. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, Olivieri M, Zaccari G, Gandolfo GM, Galli M (1994) Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 84(12):4203-4208
23. Diz-Küçükkaya R, Hacihanefioğlu A, Yenerel M, Turgut M, Keskin H, Nalçaci M, Inanç M (2001) Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 98(6):1760-1764
24. Cines DB, Liebman H, Stasi R (2009) Pathobiology of secondary immune thrombocytopenia. Semin Hematol 46(1 Suppl 2):S2-S14
25. Park SH, Kim JY, Kim SK, Choe JY, Kim SG, Ryoo HM (2010) Regulatory T-cells in systemic lupus erythematosus-associated thrombocytopenia: a comparison with idiopathic thrombocytopenic purpura. Lupus 19(7):888-889
26. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168-186
27. Galindo M, Khamashta MA, Hughes GR (1999) Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome. Rheumatology (Oxford) 38(9):848-853
28. Boyle S, White RH, Brunson A, Wun T (2013) Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood 121(23): 4782-4790
29. Matzdorff A, Beer JH (2013) Immune thrombocytopenia patients requiring anticoagulatio- -aneuvering between Scylla and Charybdis. Semin Hematol 50(Suppl 1):S83-S88
30. Cheng Y, Wong RS, Soo YO et al (2003) Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 349(9):831-836
31. Mazzucconi MG, Fazi P, Bernasconi S et al (2007) Therapy with high-dose dexamethasone [HDDXM] in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood 109(4):1401-1407
32. Ruiz-Irastorza G, Crowther M, Branch W et al (2010) Antiphospholipid syndrome. Lancet 376:1498-1509
33. Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:1033-1044
34. Hall S, McCormick JL Jr, Greipp PR, Michet CJ Jr, McKenna CH (1985) Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. Ann Intern Med 102(3): 325-328
35. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM (2000) Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 108(3):198-204
36. Sultan SM, Begum S, Isenberg DA (2003) Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 42(2):230-234
37. Hazeltine M, Rauch J, Danoff D et al (1998) Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs and hypocomplementemia. J Rheumatol 15:80-86
38. Del Papa N, Meroni PL, Barcellini W, Borghi MO, Fain C, Khamashta M, Tincani A, Balestrieri G, Hughes GR (1992) Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol 10(4):395-399
39. Rottem M, Krause I, Fraser A, Stojanovich L, Rovensky J, Shoenfeld Y (2006) Autoimmune hemolytic anaemia in the antiphospholipid syndrome. Lupus 15(7):473-477
40. Lang B, Straub RH, Weber S, Röther E, Fleck M, Peter HH (1997) Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus 6(8):652-655
41. Pullarkat V, Ngo M, Iqbal S, Espina B, Liebman HA (2002) Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism. Br J Haematol 118(4):1166-1169
42. Hendrick AM (2003) Auto-immune haemolytic anaemia-a high-risk disorder for thromboembolism? Hematology 8(1):53-56
43. Cabral AR, Cabiedes J, Alarcón-Segovia D (1990) Haemolytic anaemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes. J Autoimmun 3(6):773-787
44. Petz LD, Garratty G (2004) Immune hemolytic anemias, 2nd edn. Churchill Livingstone, Philadelphia
45. Barcellini W, Clerici G, Montesano R, Taioli E, Morelati F, Rebulla P, Zanella A (2000) In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol 111:452-460
46. Valent P, Lechner K (2008) Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr 120(5-6):136-151
47. Alba P, Karim MY, Hunt BJ (2003) Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 12:633-635
48. Kotb R, Pinganaud C, Trichet C, Lambotte O, Dreyfus M, Delfraissy JF et al (2005) Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study. Eur J Haematol 75:60-64
49. Barcellini W, Zanella A (2011) Rituximab therapy for autoimmune haematological diseases. Eur J Intern Med 22:220-229
50. Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Di Battista ML, Bona E et al (2012) Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biological studies. Blood 119:3691-3697
51. Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Di Bona E, Fattizzo B et al (2013) Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia. Eur J Haematol 91:546-551
52. Barros MM, Blajchman MA, Bordin JO (2010) Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Trans Med Rev 24: 195-210
53. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB (1993) Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol 44:237-242
54. Lechner K, Jager U (2010) How I treat autoimmune hemolytic anemias in adults. Blood 16:1831-1838
55. Crowther M, Chan YL, Garbett IK, Lim W, Vickers MA, Crowther MA (2011) Evidence- based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood 118:4036-4040
56. Berentsen S, Tjønnfjord GE (2012) Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 26:107-115
57. Berentsen S, Randen U, Vagan AM, Hjorth-Hansen H, Vik A, Dalgaard J et al (2010) High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood 116:3180-3184
58. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA (2002) High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood 100:704-706
59. Carson KR, Beckwith LG, Mehta J (2010) Successful treatment of IgM-mediated autoimmune haemolytic anemia with bortezomib. Blood 115:915
60. Roth A, Huttmann A, Rother RP, Duhrsen U, Philipp T (2009) Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease. Blood 113:3485-3486
61. Wouters D, Stephan F, Strengers P, de Haas M, Brower C, Hagenbeek A et al (2013) C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia. Blood 121:1242-1244
62. Arbach O, Funck R, Seibt F, Salama A (2012) Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. Transfus Med Hemother 39:221-223
63. Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D, EBMT Autoimmune Disease Working Party [ADWP]; Paediatric Diseases Working Party [PDWP] (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 47(6):770-790
64. Arvieux J, Jacob MC, Roussel B, Bensa JC, Colomb MG (1995) Neutrophil activation by antibeta 2 glycoprotein I monoclonal antibodies via Fc gamma receptor II. J Leukoc Biol 57(3):387-394
65. Cervera R, Font J, López-Soto A, Casals F, Pallarés L, Bové A, Ingelmo M, Urbano-Márquez A (1990) Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 49(2):109-113
66. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Franz J, Selva A, Ingelmo M et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 96(1):3-9